Intraoperative imaging system (IOI) is used during surgery to get better resolution of the body section. IOI is used in various complex surgery by providing real-time imaging solution to minimize any mistakes during surgery. It includes minimally invasive surgery, orthopedic surgery, neurosurgery, interventional neurovascular procedures, repairing congenital abnormalities, removal of traumatic blood clots and aneurysm surgery. Therefore, IOI precisely assesses monitoring and helps to control of surgical procedure. Moreover, various advanced intraoperative devices used include magnetic resonance imaging (iMRI) mobile c-arms, computed tomography (CT) and ultrasound.
Ask For A Sample Copy Of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/994
The intraoperative imaging market is gaining significant traction due to rising incidence of brain tumors. For instance, according to Cancer Research UK, in 2014, approximately 10,981 new cases of brain tumors were estimated. Moreover, according to Cure Brain Cancer Foundation, 2017, around 1,600 brain cancer is estimated to be diagnosed each year in Australia. Thus, rising incidence of brain tumors indicating the need of precise treatment management, is expected to boost the growth of the intraoperative imaging market over the forecast period.
Key features of the study:
This report provides in-depth analysis of the intraoperative imaging market and its device type, market size (US$ Million), and Cumulative Annual Growth Rate (CAGR %) for the forecast period: 2017 – 2025, considering 2017 as the base year.
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players.
It profiles leading players in the intraoperative imaging market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans.
Increasing prevalence of brain tumors and the growing need for surgery as a treatment option is expected to fuel growth of intraoperative imaging market. For instance, according to Cancer Research U.K, in 2014, around 10,981 new cases of brain tumors, CNS, and intracranial tumors were registered in U.K. The Cancer Research U.K stated in between 2014 and 2035 brain tumors is projected to rise up by 6%, which will be 22 cases per 100,000 people in the U.K. Moreover, according to the National Brain Tumor Society, in 2017, around 550,042 cases of benign tumors and over 138,054 cases of malignant tumors were estimated in the U.S.
The National Brain Tumor Society analyzed that around 28,000 children aged 0 to 19 years are expected to be diagnosed with brain tumor and over 4,830 new cases of primary malignant and non-malignant brain and CNS tumors are expected to be diagnosed in the U.S in the next few years. Therefore, rising prevalence of brain tumor will indicate need of surgery as treatment option, in turn contributing to the growth of the intraoperative imaging market over the forecast period. Click To Read More On Intraoperative Imaging Market